Comparing Acupuncture With Medication to Reduce Depression, Anxiety and Comorbid Sleep Disorders in China
Recruiting · NCT07552246 · Interventional (participants receive a specific treatment) · Lead sponsor: Duke Kunshan University
View the official record on ClinicalTrials.gov →Interventions studied
AcupuncturePsychotropic Drugs
What this trial is about
The main objective of this study is to compare medication (usual care; active comparator) with acupuncture (as experimental intervention) to identify the most (cost)effective and environmentally sustainable intervention to reduce depression, anxiety and comorbid sleep disorders in adults (18-65) in China.
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Chinese nationals 18-65 years old
- At least one of the screening scores below suggestive of depression/anxiety tendencies:
- Depressive state: Depression Self-Rating Scale (SDS) raw score ≥43; standard score ≥53 (27)
- Anxiety state: Anxiety Self-Rating Scale (SAS) raw score ≥40; standard score ≥50 (28) Note: (standard score = raw score X 1.25)
Exclusion criteria
- Patients with severe comorbid physical illnesses that prevent them from completing the full course of treatment;
- Patients with a risk of suicide;
- Patients with a history of head trauma, loss of consciousness, or severe mental disorders;
- Patients with drugs or alcohol abuse;
- Patients who have received physical treatment methods within the past 3 months;
- Patients who have received antidepressant or antipsychotic medication treatment within the past 3 months;
- Patients with severe skin lesions or skin diseases.
Where it is running
1 location listed.
- Kunshan Mental Health Center and Kunshan Hospital of Traditional Chinese Medicine - Kunshan, Jiangsu, China